Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1 1

Status

Completed 18Unknown 9Recruiting 7Not yet recruiting 4Terminated 3Active not recruiting 3Withdrawn 2

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 42CNS 37Genitourinary 33Thoracic 28Breast 28Head & Neck 19Lymphoid 18Sarcoma 17Dermatologic 10Gynecologic 8Other solid neoplasm 4Tumor-Agnostic 3Plasma cell 2Other hematologic neoplasm 2Other neoplasm 1NET 1Endocrine 1

Conditions

Neoplasms 2Neoplasm Metastasis 1

Interventions

pembrolizumab 18Specimen Handling 9Magnetic Resonance Spectroscopy 9Bevacizumab 8Biopsy 7Paclitaxel 6Nivolumab 6atezolizumab 5Cyclophosphamide 5Surveys and Questionnaires 4Standard of Care 4Practice Guidelines as Topic 4Oxaliplatin 4Ipilimumab 4osimertinib 3niraparib 3durvalumab 3cemiplimab 3avelumab 3X-Rays 3Radiotherapy 3Radiosurgery 3Radiation 3Pemetrexed 3Leucovorin 3Irinotecan 3Interviews as Topic 3Fluorouracil 3Carboplatin 3trastuzumab deruxtecan 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × Radiotherapy × Tumor-Agnostic × Clear all
NCT01428895 2026-03-06

Femoral Bone Metastases

University Health Network, Toronto

Phase NA Active not recruiting
180 enrolled
Tumor-Agnostic

Neoplasms

NCT02560636 2026-01-06

PLUMMB

Royal Marsden NHS Foundation Trust

Phase 1 Active not recruiting
34 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT04375891 2025-02-04

Radiation Therapy Alone Versus Radiation Therapy Plus Radiofrequency Ablation (RFA)/Vertebral Augmentation

Baptist Health South Florida

Phase NA Active not recruiting
63 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡